ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 365601 | Rec_0373016 | Lysozyme (EC 3.2.1.17) |
MQTGKKLKYGLSAAMLALIAAGASAPQLLDQFLQEREGNTLVAVRDNGGVWSVCRGVTRIDGKPVVKGQRLTQSQCDHYNAIERDKALAWVNKNVHIPLTEPQKTGIASFCPYNIGPGKCFPSTFYRKLNVGDRKGACAEIRRWVYDGGKDCHNRKNQCYGQVIRRDQESALACWGIDQ |
Salmonella enterica subsp. enterica serovar Lattenkamp [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 365602 | Rec_0373017 | B1-C10 |
VKRFKKFFRKLKKSV |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
MCF-7/Taxol |
3.2±0.4 μM | IC50 |
26083110 | - |
YES |
| 365603 | Rec_0373018 | DdrB-ParB domain-containing protein |
MSDTSRRSPMAPTKLSPQDYRRAVGNHLKTYEGVVPRIYTDDDGIPTMGSGVALAAKNQDKIFVLRDLNEIGAEISGDPAKPYRFTAEEAKLLNDTVGKLNDSQLTDRVRKSEAQKLIPPYKPGETTVDGNKFGFTLSDERIAKQAEAAWTVHRDRAIQTVRTQAKARGWSKDETNAYIKSLEGSQQEIALTSLAYNGVPTPKATGAMLDGDPVALRQEILYRSNPPEGGAKRKGYAERRKTEADLASGPLEDWTQQQREQLRQSEASPDAKRYRDTFPETFPQYGPPQDTGLSTLRPEPRPQDAVDQGEPSPQPEPQPAPEREQKQSEAPADPRVSAMTEMAAMPVANPGRSALLKPVEKLTEGEMMDMIASAQGDYRGWRSGDPLKAHTYEKVQDWHASIYGDQPQGNDGGKPIEPMPIRPIPEQPSPHTTPQGEDLWQATARLGGKLAAAAGMDGYAQTVQGLQRGLNMLNNANPLPARSAAYGPYTKLGPVDEDGQYGPQTDFALKHATARLGPAKVEDGLALGRFNTFARAAQSSGNAEGLENKTHAIFGPLLHKDDQAPKVEGGALQMALNGFGQNLKVDNWIGPKTTQAFADVLKEQDSDTLTRSLGRELGML |
Magnetospirillum aberrantis SpK [Bacterium] |
Antimicrobial, Bacteriolytic, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 365604 | Rec_0373019 | Unnamed |
DINGKLFLPKHALSQDVCTYRDFTYKTVEIPGCPRHVSPYFS |
not reported [other] |
Metabolic |
- |
- | - |
39514414 | - |
NO |
| 365605 | Rec_0373020 | Indolicidin [W4,6,8,9,11Y] |
ILPYKYPYYPYRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli IFO 12734 |
100.0 μg/mL | MIC |
11695650;20196123 | - |
YES |
| 365606 | Rec_0373021 | GN-4 |
RWKKWWRWL |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
- |
- | - |
25941221 | - |
NO |
| 365607 | Rec_0373022 | NLTP_PYRCO |
CCNGIKTINGLAKTTPDRQAACNCLKNLAGSVSGVNPGNAESLPGKCGVNMASSAVIKLALVVALCMAVSVAHAITCSQVSANLAPCINYVRSGGAVPPAVPYKISTSTNCATVK |
Pyrus communis [Plant] |
Signaling |
- |
- | - |
- | - |
NO |
| 365608 | Rec_0373023 | Unnamed |
VRTLLSQVNK |
Homo sapiens [Animal] |
Anticancer, Immunogenic |
melanoma; HLA-B*27:05 |
- | Flow cytometry |
28678778 | - |
YES |
| 365609 | Rec_0373024 | Caseicin B [E4A] |
VLNANLLR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Klebsiella pneumoniae NCIMB 13218 |
2500 μM | MIC |
22247170 | - |
YES |
| 365610 | Rec_0373025 | Cathelicidin-BF-15 [F4,8W;L11W,S14W,V15W] |
VKRWKKFWRKWKKWW |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli ATCC 25922 |
18.75 μg/mL | MIC |
26881456 | - |
YES |
| 365611 | Rec_0373026 | HLP6 (HLP2 peptide derivative) |
FQWQRNPRKVR |
Synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-positive,Anti-Gram-negative |
Clinical isolates: Acinetobacter sp |
- | - |
9596699 | - |
YES |
| 365612 | Rec_0373027 | SP13-13 |
KRRKLAFRAFRFALKAVLKK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Clavibacter michiganensis subsp. michiganensis DSM 46294 |
0.5 μg/mL | MIC |
23951222 | - |
YES |
| 365613 | Rec_0373028 | SLAY-screened peptide P3451 |
PIANEDHRRIAMSMPFAISRN |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
recombinant Escherichia coli surface-display screening |
- | SLAY screening |
29307492 | - |
NO |
| 365614 | Rec_0373029 | LP26 |
XXXXX |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal, Anti-Gram-positive, Anti-Gram-negative |
Candida albicans ATCC 24433 |
100 μg/mL | MIC |
23819506 | - |
YES |
| 365615 | Rec_0373030 | Chicken AvBD4 |
RVSMRCGYRGTFCFPGKCPRGNRYLGVCRPGHSCCRW |
Apteryx australis [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
- | Mex pooled growth assay (OD_ID at 4.5 h; Wald adjusted p-value) |
35260685 | - |
YES |
| 365616 | Rec_0373031 | AvBD-12 [D3H,D8Q,E21Y,E29S], AvBD-12/6 |
GPHSCNHQRGLCRVGNCNPGYYLAKYCFSPVILCCKPLSPTPTKT |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 25922 |
32 μg/mL | MBC |
28231771 | - |
YES |
| 365617 | Rec_0373032 | Peptidoglycan hydrolase |
MNLRLLIASIVTSLLLVSCGSSKKVVNNTNKNVIIEHEEKKPDVPQLEQIEKPLKTNGNHTLAYIHKFAPIAVREMNEYGIPASITLAQGVLESGSGRSPLAIRSNNHFGIKCHRGWKGKSVTHDDDEKGECFRKYKYPETSYEDHSKFLVSRKRYAGLFRLRKTDYKGWAYGLKRAGYATDRRYPQKLIGIIKKYNLTRYDRVKTKKNKVSKPTYSTGNYYKVQKGDTLYSISRKFKISVDQLKEVNGLKSNALSIGQHLLIN |
Tenacibaculum holothuriorum [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 365618 | Rec_0373033 | MZ-4-169 |
YRDAIFTNSYRKVLXQLSARKLLQDIXSR |
synthetic construct [Synthetic] |
Receptor antagonist, Signaling peptide |
rat pituitary cells / GHRH receptor |
3 nM | GH-release inhibition assay in superfused rat pituitary cells |
7991622 | - |
YES |
| 365619 | Rec_0373034 | PMAP-36 (2-17) [T9W] |
RFRRLRKKWRKRLKKI |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa ATCC 27853[LC = 4+-0.8 microg/ml] |
- | - |
25494332;25753629 | - |
YES |
| 365620 | Rec_0373035 | Unnamed |
LLFGLALIEV |
Homo sapiens [Animal] |
Anticancer |
melanoma; HLA-A*02:01 |
0.0072 μM | Predicted HLA-I binding |
14999777 | - |
NO |